Multimodal therapy mesothelioma treatment options
Patients each case is unique, so each patient will receive a customized
treatment plan of mesothelioma. The surgical team, medicine and Oncology
specialist will work together to determine the right combination of
mesothelioma treatment for each patient.
When your doctor devise a treatment plan, treatment is very important, and will vary depending on the patient, physician and medical practices. This is why it is important to consult with someone who is experienced in treating mesothelioma.
For example, patients may be receiving neoadjuvant chemotherapy or radiation before surgery to shrink the tumor, making them easier to remove during surgery. Other patients may receive adjuvant, or post surgery, chemotherapy or radiation. Still others, may receive intraoperative chemotherapy and radiation treatments that are applied directly to the location of cancer patients while undergoing surgical procedures.
When your doctor devise a treatment plan, treatment is very important, and will vary depending on the patient, physician and medical practices. This is why it is important to consult with someone who is experienced in treating mesothelioma.
For example, patients may be receiving neoadjuvant chemotherapy or radiation before surgery to shrink the tumor, making them easier to remove during surgery. Other patients may receive adjuvant, or post surgery, chemotherapy or radiation. Still others, may receive intraoperative chemotherapy and radiation treatments that are applied directly to the location of cancer patients while undergoing surgical procedures.
Trimodal therapy with surgery, chemotherapy and radiation treatment is one of the most common forms of multimodal therapy for Pleural mesothelioma patients. In this case, surgery is considered the primary therapy, or the most effective treatment options, coupled with additional treatment.
The extent to which the cancer has spread is usually the biggest factor that determines whether mesothelioma patients eligible for surgery. If pleural tumors do not spread beyond the point of origin, surgery may be effective in improving the prognosis of the patient. If pleural tumor has spread beyond the point of origin to nearby organs, surgery may not offer significant benefit for patients. In the case of pleural mesothelioma is a multimodal approach, using only chemotherapy and radiation may be the best.
However, in the case of peritoneal mesothelioma with spread to nearby organs, surgery may still offer significant benefit with potential chemotherapy and radiation. In recent years, the use of an experimental therapy in combination with traditional therapies have improved survival rates and quality of life of the patient.
One experimental therapy, immunotherapy, using drugs to stimulate the immune system of the patient to kill cells of the mesothelioma. This targeted approach does not damage any healthy cells, such as chemotherapy does. Instead, it is designed to attack only the bad cells, or cells of the mesothelioma.
Additional experimental therapy is available through clinical trials is gene therapy and photodynamic therapy. Gene therapy is where the gene is damaged or missing gene is replaced with a normal gene or genes are injected into cancer cells killed eating off the cell and kill it. Photodynamic therapy using drugs specifically activated by a certain type of light that enable cancer cells, making them easier to target and destroy.
Experimental therapy-immunotherapy included-currently only available through clinical trials. Many drugs being tested in immunotherapy of mesothelioma a patient has obtained the approval of the Federal Drug Administration (FDA) for the treatment of other cancers.
The extent to which the cancer has spread is usually the biggest factor that determines whether mesothelioma patients eligible for surgery. If pleural tumors do not spread beyond the point of origin, surgery may be effective in improving the prognosis of the patient. If pleural tumor has spread beyond the point of origin to nearby organs, surgery may not offer significant benefit for patients. In the case of pleural mesothelioma is a multimodal approach, using only chemotherapy and radiation may be the best.
However, in the case of peritoneal mesothelioma with spread to nearby organs, surgery may still offer significant benefit with potential chemotherapy and radiation. In recent years, the use of an experimental therapy in combination with traditional therapies have improved survival rates and quality of life of the patient.
One experimental therapy, immunotherapy, using drugs to stimulate the immune system of the patient to kill cells of the mesothelioma. This targeted approach does not damage any healthy cells, such as chemotherapy does. Instead, it is designed to attack only the bad cells, or cells of the mesothelioma.
Additional experimental therapy is available through clinical trials is gene therapy and photodynamic therapy. Gene therapy is where the gene is damaged or missing gene is replaced with a normal gene or genes are injected into cancer cells killed eating off the cell and kill it. Photodynamic therapy using drugs specifically activated by a certain type of light that enable cancer cells, making them easier to target and destroy.
Experimental therapy-immunotherapy included-currently only available through clinical trials. Many drugs being tested in immunotherapy of mesothelioma a patient has obtained the approval of the Federal Drug Administration (FDA) for the treatment of other cancers.
Multimodal therapy mesothelioma treatment options
4/
5
Oleh
CRYPTO ENTHUSIAST
